Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | AOAH |
| Upstream (Parents) |
|---|
| (<<) DAB2 → AOAH |
| (<<) ANP32E → AOAH |
| (<<) ACVRL1 → AOAH |
| (<<) NEU1 → AOAH |
| (<<) CAPN3 → AOAH |
| (<<) CLIC2 → AOAH |
| (<<) PLA2G4A → AOAH |
| (<<) MYO15B → AOAH |
| Downstream (Children) |
|---|
| AOAH → ANP32E (>>) |
| AOAH → PNMT (>>) |
| AOAH → ERAP2 (>>) |
| AOAH → EDDM3A (>>) |
| AOAH → TACR3 (>>) |
| AOAH → PRKD1 (>>) |
| AOAH → TUB (>>) |
| AOAH → FAT2 (>>) |
| AOAH → GSPT2 (>>) |
| AOAH → BEST1 (>>) |
| AOAH → PSPN (>>) |
| AOAH → CASKIN2 (>>) |
